CAS: 926-39-6; 2-Aminoethyl Hydrogen Sulfate

该化合物是一种有机化合物,其特点是存在氨基氨基乙基硫酸盐组和硫酸盐组,通常视其形态和纯度而呈现无色的黄色液体或固体,这种化合物在水中溶解,在各种应用中有用,包括作为表面活性剂和合成其他化学品.其分子结构具有乙基链,具有氨基化合物组(-NH2)和氢硫酸盐组(-OSO3H),有助于其再活性并形成盐. 2-氨基硫酸盐在生产表面活性剂,乳化剂和个人护理产品时经常使用.此外,该化合物可能用于药物和有机合成中的试剂.然而,处理该化合物需要谨慎,因为它具有潜在的刺激性特性,特别是皮肤和眼睛.在与该物质打交道时,应当注意适当的安全措施.

结构式图片

相似化合物

2133-07-5 1908-84-5 1417738-30-7

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号141-43-5 2-氨基乙醇 | CAS号7803-63-6 硫酸氢铵 | CAS号109-58-0 2-氨基乙基氨基甲酸 | CAS号1072-53-3 1,3,2-二噁唑噻吩-2,2-二氧化物 | CAS号7664-93-9 硫酸 | CAS号497-25-6 2-恶唑烷酮 | CAS号151-56-4 氮丙啶 | CAS号2576-47-8 2-溴乙胺氢溴酸盐 | CAS号77-78-1 硫酸二甲酯 | CAS号110925-66-1 sodium,2-[[(E)-... | CAS号497-25-6 2-恶唑烷酮 | CAS号22572-38-9 2-(硫代叔丁基)乙胺 | CAS号36489-03-9 2-(乙硫基)乙胺 | CAS号23956-51-6 2-(benzylidenea... | CAS号107-15-3 乙二胺 | CAS号111-41-1 羟乙基乙二胺 | CAS号111-40-0 二乙烯三胺 | CAS号19522-69-1 N-丁基乙烯二胺 | CAS号56205-96-0 (2-amino-ethyl)...

合成工艺路线路线简述

    C.I.酸性橙108置于硫酸体系中,用89%的收率获得产物2-氨基乙醇硫酸氢酯
    参考文献:新型含氧乙酸或氧代(2-硫代噻唑啉酮-3-基)乙酮部分的1,5-二芳基-1H-吡唑-3-氧羰基衍生物的合成,晶体结构和杀真菌活性
    标题:新型含氧乙酸或氧代(2-硫代噻唑啉酮-3-基)乙酮部分的1,5-二芳基-1H-吡唑-3-氧羰基衍生物的合成,晶体结构和杀真菌活性
    摘要:由3-芳基丙烯酸甲酯通过一系列反应制备了一系列新颖的1,5-二芳基-1 H-吡唑-3-氧基衍生物,其中含有氧乙酸或氧(2-硫代噻唑并恶唑啉-3-基)乙酮部分.环化,氧化,取代,水解和缩合.其结构通过1 H-NMR,13 C-NMR,Ir和元素分析确认.此外,通过单晶x射线衍射分析确定了化合物2-(1,5-二苯基-1H-吡唑-3-基氧基)-1-(2-硫代噻唑啉酮-3-基)乙酮的晶体结构.生物测定结果表明化合物2-(5-(4-氯苯基)-1-苯基-1 H吡唑-3-基氧基)-1-(2-硫代-噻唑烷-3-基)乙酮在10μgml-1的剂量下对玉米赤霉病菌表现出中等的抑制活性.
    DOI:10.1002/jhet.1045

    海关参考信息

    专利信息


    专利号:US-5405949-A
    优先权日:1993-03-29
    标题 :Process for the synthesis of glycosaminoglycans with heparin or heparan structure modified in position 2 of the α-L-iduronic-2-O-sulfate acid
    发明人:UNGARELLI FABRIZIO; PIANI SILVANO
    权利人:ALFA WASSERMANN SPA
    摘要:A process for the synthesis of glycosaminoglycans with heparin or heparan structure modified in position 2 of the α-L-iduronic-2-O-sulfate acid in which the sulfate group is, entirely or in part, substituted with a nucleophilic group, is described. The process is carried out by treating glycosaminoglycans having heparin or heparan structure with a nucleophilic reagent in alkaline solution.

    专利号:US-5410039-A
    优先权日:1993-03-29
    标题 :Process for the synthesis of glycosaminoglycans containing α-L-galacturonic acid substituted with nucleophilic groups in position 3
    发明人:UNGARELLI FABRIZIO; PIANI SILVANO
    权利人:ALFA WASSERMANN SPA
    摘要:A process for the synthesis of glycosaminoglycans in which one of the α-L-iduronic-2-O-sulfate acid saccharide units, which is characteristic of glycosaminoglycans with heparin or heparan structure, has undergone a structural modification, entirely or in part, with transformation into α-L-galacturonic acid substituted in position 3 with nucleophilic groups, is described. The process is carried out by treating glycosaminoglycans having heparin or heparan structure with a nucleophilic reagent in alkaline solution.

    专利号:US-9777022-B2
    优先权日:2012-10-02
    标题 :Process for the preparation of macrocyclic polyazacarboxylate ligands and chelates
    发明人:MOORE DENNIS A; RAJAGOPALAN RAGHAVAN
    权利人:MALLINCKRODT LLC; GUERBET SA
    摘要:The present disclosure relates generally to a process for the synthesis of 1,4,7,10-tetraazacyclododecane ligands, chelates, and derivatives thereof. In particular, the present disclosure is directed to a process for the synthesis of 1,4,7,10-tetraaza-1,4,7,10-tetrakis(carboxymethyl)cyclododecane (DOTA) ligands, corresponding DOTA-metal chelates, and various derivatives thereof.

    专利号:US-10221132-B2
    优先权日:2016-10-24
    标题:Process for the preparation of a sulfur-amine
    发明人:BARATELLA MARCO; GABOARDI MAURO; CASTALDI GRAZIANO; OLDANI ERMINIO
    权利人:CHEMELECTIVA SRL
    摘要:The present invention relates to a process for the synthesis of cysteamine or a salt thereof.

    专利号:US-2005080260-A1
    优先权日:2003-04-22
    标 题 :Preparation of prodrugs for selective drug delivery
    发明人:MILLS RANDELL L; WU GUO-ZHANG
    摘要:Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.

    专利号:US-8877977-B2
    优先权日:2011-11-25
    标题 :Synthesis of polyalkylenepolyamines having a low color index by homogeneously catalyzed alcohol amination in the presence of hydrogen
    发明人:STRAUTMANN JULIA; SCHAUB THOMAS; HUEFFER STEPHAN; MAAS STEFFEN; PACIELLO ROCCO
    权利人:STRAUTMANN JULIA; SCHAUB THOMAS; HUEFFER STEPHAN; MAAS STEFFEN; PACIELLO ROCCO; BASF SE
    摘要:Process for the preparation of polyalkylenepolyamines by homogeneously catalyzed alcohol amination, in which aliphatic amino alcohols are reacted with one another or aliphatic diamines or polyamines are reacted with aliphatic diols or polyols with the elimination of water in the presence of a homogeneous catalyst and in the presence of hydrogen gas. Polyalkylenepolyamines obtainable by such processes and polyalkylenepolyamines comprising hydroxy groups, secondary amines or tertiary amines. Uses of such polyalkylenepolyamines as adhesion promoters for printing inks, adhesion promoters in composite films, cohesion promoters for adhesives, crosslinkers/curing agents for resins, primers for paints, wet-adhesion promoters for emulsion paints, complexing agents and flocculating agents, penetration assistants in wood preservation, corrosion inhibitors, immobilizing agents for proteins and enzymes.
    上海常丰生物医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chainpharm.com
    企业联系电话:021-61727342👤
    📞上海常丰生物医药科技有限公司 ⚠️参考联系方式
    联系人:张经理
    电话:021-61727342
    手机:13611721451
    传真:021-33275302
    邮箱:sales@chainpharm.com
    通信地址: 上海金山区金瓯路188号
    邮编: 201512
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海金山区金瓯路188号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    常州金坛光大科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.guangda-chem.com
    企业联系电话:13306149555👤
    📞常州金坛光大科技有限公司 ⚠️参考联系方式
    联系人:李光天
    电话:13306149555
    手机:13306149555
    传真:0519-82356599
    邮箱:sales@guangda-chem.com
    通信地址: 江苏省常州市金坛区指前镇工业园区园区大道3号
    邮编: 213200
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市金坛区指前镇工业园区园区大道3号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:New Series Of Morpholine And 1,4-Oxazepane Derivatives As Dopamine D4 Receptor Ligands: Synthesis And 3D-Qsar Model
    作者:Karine Audouze,Elsebet østergaard Nielsen,Dan Peters |发布日期:2004.6.1
    摘要:Since The Identification Of The Dopamine D(4) Receptor Subtype And Speculations About Its Possible Involvement In Schizophrenia, Much Work Has Been Put Into Development Of Selective D(4) Ligands. These Selective Ligands May Be Effective Antipsychotics Without Extrapyramidal Side Effects. This Work Describes The Synthesis Of A New Series Of 2,4-Disubstituted Morpholines And 2,4-Disubstituted 1,4-Oxazepanes

    合成参考文献


    摘要:S13 | EUCOSMETICS | Combined Inventory of Ingredients Employed in Cosmetic Products (2000) and Revised Inventory (2006) | DOI:10.5281/zenodo.2624118
    参考文献:10.1007/bf01962705
    摘要:Löscher W. Pharmacological, toxicological and neurochemical effects of Δ2(E)-valproate in animals. Pharmaceutisch Weekblad Scientific Edition. 1992 Jun;14(3):139–43. doi: 10.1007/bf01962705.
    参考文献:10.1007/bf00634242
    摘要:Dennis T, Curet O, Nishikawa T, Scatton B. Further evidence for, and nature of, the facilitatory GABAergic influence on central noradrenergic transmission. Naunyn Schmiedebergs Arch Pharmacol. 1985 Nov;331(2-3):225–34. doi: 10.1007/bf00634242.
    参考文献:10.1007/bf02581350
    摘要:Quatraro A, Consoli G, Stante A, Minei A, Ceriello A, Passariello N, Giugliano D. Impaired insulin secretion in human diabetes mellitus. Effect of pharmacological activation of gamma-aminobutyric acid system. Acta Diabetol Lat. 1986 Jan;23(1):23–8. doi: 10.1007/bf02581350.
    参考文献:10.1007/bf00975049
    摘要:Ghosh(née Biswas) S, Poddar MK. Higher environmental temperature-induced increase in body temperature: Involvement of serotonin in GABA mediated interaction of opioidergic system. Neurochemical Research. 1993 Dec;18(12):1287–92. doi: 10.1007/bf00975049.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知